Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer-Reference-Cited by-同舟云学术

Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer

Published:2019-03 Issue:3 Volume:30 Page:412-417
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Evron E.,Ben-David A.M.,Goldberg H.,Fried G.,Kaufman B.,Catane R.,Pfeffer M.R.,Geffen D.B.,Chernobelsky P.,Karni T.,Abdah-Bortnyak R.,Rosengarten O.,Matceyevsky D.,Inbar M.,Kuten A.,Corn B.W.

Funder

Israeli Cancer Association

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/30/3/412/28255088/mdy515.pdf

Reference26 articles.

1. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2;King;Science,2003

2. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Kuchenbaecker;Sci Rep,2017

3. Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis;De Felice;Ann Surg Oncol,2015

4. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation;Meijers-Heijboer;N Engl J Med,2001

5. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group;Rebbeck;J Clin Oncol,2004

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of Clinical-Pathological Parameters for Exclusion of BRCA1/2 Mutation Carriers as Candidates for Partial Breast Irradiation;Practical Radiation Oncology;2024-09

2. Homologous recombination deficiency status predicts response to immunotherapy‐based treatment in non‐small cell lung cancer patients;Thoracic Cancer;2024-07-30

3. Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation;JAMA Network Open;2024-06-25

4. Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy;European Journal of Surgical Oncology;2024-06

5. Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on BRCA1, BRCA2, and Lynch Syndrome;American Society of Clinical Oncology Educational Book;2024-06